MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1056/nejmoa1211103

Медицинская библиотека · The New England journal of medicine · 2012

Variant of TREM2 associated with the risk of Alzheimer's disease.

Jonsson Thorlakur, Stefansson Hreinn, Steinberg Stacy, Jonsdottir Ingileif, Jonsson Palmi V, Snaedal Jon, Bjornsson Sigurbjorn, Huttenlocher Johanna, Levey Allan I, Lah James J, Rujescu Dan, Hampel Harald, Giegling Ina, Andreassen Ole A, Engedal Knut, Ulstein Ingun, Djurovic Srdjan, Ibrahim-Verbaas Carla, Hofman Albert, Ikram M Arfan, van Duijn Cornelia M, Thorsteinsdottir Unnur, Kong Augustine, Stefansson Kari

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Sequence variants, including the ε4 allele of apolipoprotein E, have been associated with the risk of the common late-onset form of Alzheimer's disease. Few rare variants affecting the risk of late-onset Alzheimer's disease have been found.

METHODS

We obtained the genome sequences of 2261 Icelanders and identified sequence variants that were likely to affect protein function. We imputed these variants into the genomes of patients with Alzheimer's disease and control participants and then tested for an association with Alzheimer's disease. We performed replication tests using case-control series from the United States, Norway, The Netherlands, and Germany. We also tested for a genetic association with cognitive function in a population of unaffected elderly persons.

RESULTS

A rare missense mutation (rs75932628-T) in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2), which was predicted to result in an R47H substitution, was found to confer a significant risk of Alzheimer's disease in Iceland (odds ratio, 2.92; 95% confidence interval [CI], 2.09 to 4.09; P=3.42×10(-10)). The mutation had a frequency of 0.46% in controls 85 years of age or older. We observed the association in additional sample sets (odds ratio, 2.90; 95% CI, 2.16 to 3.91; P=2.1×10(-12) in combined discovery and replication samples). We also found that carriers of rs75932628-T between the ages of 80 and 100 years without Alzheimer's disease had poorer cognitive function than noncarriers (P=0.003).

CONCLUSIONS

Our findings strongly implicate variant TREM2 in the pathogenesis of Alzheimer's disease. Given the reported antiinflammatory role of TREM2 in the brain, the R47H substitution may lead to an increased predisposition to Alzheimer's disease through impaired containment of inflammatory processes. (Funded by the National Institute on Aging and others.).

Для цитирования: Jonsson Thorlakur, Stefansson Hreinn, Steinberg Stacy, Jonsdottir Ingileif, Jonsson Palmi V, Snaedal Jon, Bjornsson Sigurbjorn, Huttenlocher Johanna, Levey Allan I, Lah James J, Rujescu Dan, Hampel Harald, Giegling Ina, Andreassen Ole A, Engedal Knut, Ulstein Ingun, Djurovic Srdjan, Ibrahim-Verbaas Carla, Hofman Albert, Ikram M Arfan, van Duijn Cornelia M, Thorsteinsdottir Unnur, Kong Augustine, Stefansson Kari. Variant of TREM2 associated with the risk of Alzheimer's disease.. The New England journal of medicine. 2012. DOI: 10.1056/nejmoa1211103.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.